Tonix Pharmaceuticals Holding Corp Revenue per Employee (TNXP), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tonix Pharmaceuticals Holding Corp   (NASDAQ: TNXP)
 

Tonix Pharmaceuticals Holding 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 423.83% in the third quarter 2026, year on year to cumulative value of $43 million, Tonix Pharmaceuticals Holding 's revenue per employee grew on a trailing twelve months basis to $ 303,141, this is below the company average.
Within the Healthcare sector Employees of 445 other companies have achieved higher revenue per employee. While Tonix Pharmaceuticals Holding 's total ranking has deteriorated compared to the previous quarter from 2300 to 3218. Tonix Pharmaceuticals Holding has 142 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TNXP Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 423.83 % 577.88 % 183.16 % 108.75 % 16.58 %
Sales per Employee (TTM) $ 303,141 204,944 123,634 92,303 72,528
TNXP's Total Ranking # 3218 # 2300 # 2605 # 2984 #
Seq. Revenue Change 27.24 % 96.92 % 27.61 % 63.83 % 64.66 %

TNXP Company Profile >> Back to TNXP Efficiency Comparisons >> Compare TNXP Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 446
Overall Market # 3218

Revenue per Employee Statistics
High Average Low
$ 123,634 $ 83,342 $ 69,232
(Mar 31 2026)   (Jun 30 2025)



Financial Statements
Tonix Pharmaceuticals Holding 's Revenue MRQ $ 17 Millions Visit TNXP's Income Statement
Tonix Pharmaceuticals Holding 's Revenues TTM $ 43 Millions Visit TNXP's aggregate revenue growth
What are TNXP's Sales? Visit TNXP's Sales by Segment




Other Ratios
Tonix Pharmaceuticals Holding 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TNXP's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TNXP's Competitors
Revenue per Employee for TNXP's Suppliers
Revenue per Employee for TNXP's Customers

You may also want to know
TNXP's Sales Growth Rates TNXP's Pe Price to earnings ratio TNXP's Receivables Turnover Ratio TNXP's Stock Quote
TNXP's Net Income Growth Rates TNXP's Ps Price to Sales ratio TNXP's Sales per Employee TNXP's Asset Turnover Ratio
TNXP's Net Margin TNXP's Pb Price to Book ratio TNXP's Financial Strength Ratios TNXP's Dividend Payout Ratio
Date modified: 2026-11-10T13:47:44+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Adc Therapeutics Sa  439,756.48 $ 84.873  Million 193 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
Abbott Laboratories  419,382.61 $ 48,229.000  Million 115,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Regenxbio Inc   414,854.45 $ 153.911  Million 371 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Lemaitre Vascular Inc   412,119.08 $ 269.938  Million 655 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Strata Critical Medical Inc   393,386.02 $ 236.425  Million 601 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.